×
About 57,830 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  27,769 results

Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with ...
https://doi.org/10.3350/cmh.2020.0023
Clinical and Molecular Hepatology; Baatarkhuu O, Lee JS et. al.

Nov 27th, 2020 - Ledipasvir/sofosbuvir (LDV/SOF) shows high efficacy and safety in patients with genotype 1-hepatitis C virus (HCV). We aimed to investigate the efficacy and safety of LDV/SOF in real-world Mongolian patients. Between 2015 to 2019, 23 (0.5%) and 5,...

Sudomotor Changes in Hepatitis C Virus Infection with or without Diabetes Mellitus: A P...
https://doi.org/10.4269/ajtmh.20-0612
The American Journal of Tropical Medicine and Hygiene; Tharwa ES, Mohamed A et. al.

Nov 27th, 2020 - Hepatitis C virus (HCV) infection can affect the neurological system, and neuropathy is one of these manifestations. Hepatitis C virus infection is associated with diabetes mellitus (DM) type II, and diabetic patients are at higher risk of acquiri...

Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can't Do?
https://doi.org/10.1093/infdis/jiaa420
The Journal of Infectious Diseases; Kappus MR, Wolfe CR et. al.

Nov 27th, 2020 - The opioid epidemic has resulted in an increase in organ donors with hepatitis C virus (HCV) infection in the United States. With the development of direct-acting antiviral regimens that offer high sustained virologic response rates even in the se...

Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have...
https://doi.org/10.1093/infdis/jiaa096
The Journal of Infectious Diseases; Rockstroh JK, Boesecke C

Nov 27th, 2020 - Since 2002, a global epidemic of acute hepatitis C virus (HCV) infection has been noted in men who have sex with men (MSM). Transmission of HCV, particularly in the context of traumatic sex practices that increase the risk of blood-blood contacts ...

We Must Do Better: Addressing HCV Treatment Barriers in Persons Who Inject Drugs in the...
https://doi.org/10.1093/infdis/jiaa574
The Journal of Infectious Diseases; Trooskin SB, Dore G et. al.

Nov 27th, 2020 - The opioid epidemic in the United States, along with a lack of adequate harm reduction services, has contributed to a sharp rise in hepatitis C virus (HCV) infections. Despite considerable evidence of the effectiveness of HCV treatment in people w...

see more →

Guidelines  47 results

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
https://annals.org/aim/fullarticle/2751913/prevention-diagnosis-evaluation-treatment-hepatitis-c-virus-infection-chronic-kidney

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

Aug 27th, 2019 - The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or li...

HIV and Viral Hepatitis - CDC
https://www.cdc.gov/hiv/pdf/library/factsheets/hiv-viral-hepatitis.pdf

Jun 26th, 2019 - People with HIV infection are affected disproportionally by viral hepatitis. Nearly 75% of people with HIV who report a history of injection drug use also are infected with hepatitis C virus (HCV).

Hepatitis C Questions and Answers for Health Professionals
https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm

Apr 8th, 2019 - What are the case definitions for reportable hepatitis C virus (HCV) infections? The specific viral cause of illness cannot be determined based solely on signs, symptoms, history, or current risk factors, but must be verified by specific serologic...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  28,705 results

Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with ...
https://doi.org/10.3350/cmh.2020.0023
Clinical and Molecular Hepatology; Baatarkhuu O, Lee JS et. al.

Nov 27th, 2020 - Ledipasvir/sofosbuvir (LDV/SOF) shows high efficacy and safety in patients with genotype 1-hepatitis C virus (HCV). We aimed to investigate the efficacy and safety of LDV/SOF in real-world Mongolian patients. Between 2015 to 2019, 23 (0.5%) and 5,...

Sudomotor Changes in Hepatitis C Virus Infection with or without Diabetes Mellitus: A P...
https://doi.org/10.4269/ajtmh.20-0612
The American Journal of Tropical Medicine and Hygiene; Tharwa ES, Mohamed A et. al.

Nov 27th, 2020 - Hepatitis C virus (HCV) infection can affect the neurological system, and neuropathy is one of these manifestations. Hepatitis C virus infection is associated with diabetes mellitus (DM) type II, and diabetic patients are at higher risk of acquiri...

Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can't Do?
https://doi.org/10.1093/infdis/jiaa420
The Journal of Infectious Diseases; Kappus MR, Wolfe CR et. al.

Nov 27th, 2020 - The opioid epidemic has resulted in an increase in organ donors with hepatitis C virus (HCV) infection in the United States. With the development of direct-acting antiviral regimens that offer high sustained virologic response rates even in the se...

Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have...
https://doi.org/10.1093/infdis/jiaa096
The Journal of Infectious Diseases; Rockstroh JK, Boesecke C

Nov 27th, 2020 - Since 2002, a global epidemic of acute hepatitis C virus (HCV) infection has been noted in men who have sex with men (MSM). Transmission of HCV, particularly in the context of traumatic sex practices that increase the risk of blood-blood contacts ...

We Must Do Better: Addressing HCV Treatment Barriers in Persons Who Inject Drugs in the...
https://doi.org/10.1093/infdis/jiaa574
The Journal of Infectious Diseases; Trooskin SB, Dore G et. al.

Nov 27th, 2020 - The opioid epidemic in the United States, along with a lack of adequate harm reduction services, has contributed to a sharp rise in hepatitis C virus (HCV) infections. Despite considerable evidence of the effectiveness of HCV treatment in people w...

see more →

News  1,273 results

Patients Cured of HCV Still at High Liver Cancer Risk
https://www.medscape.com/viewarticle/941615

Nov 25th, 2020 - NEW YORK (Reuters Health) - The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests. "The new hep...

Combo DAA Treatments May Benefit Patients With Resistant HCV Genotype 3
https://www.medscape.com/viewarticle/941464

Nov 22nd, 2020 - Patients with hepatitis C virus (HCV) genotype 3 infection have shown resistance to direct-acting antiviral (DAA) treatments. However, a meta-analysis of 34 research reports found that DAA combo treatment can be effective in achieving sustained vi...

Opt-Out Policy at a Syringe Service Program Increased HIV/HCV Testing
https://www.staging.medscape.com/viewarticle/941269

Nov 18th, 2020 - Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program. Researchers conducted a retrospective comparative analysis o...

Opt-Out Policy at a Syringe Service Program Increased HIV/HCV Testing
https://www.medscape.com/viewarticle/941269

Nov 18th, 2020 - Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program. Researchers conducted a retrospective comparative analysis o...

Vanquishing Hepatitis C: A Remarkable Success Story
https://www.staging.medscape.com/viewarticle/940796

Nov 16th, 2020 - In celebration of Medscape's 25th birthday, we are highlighting key breakthroughs that have defined the last quarter century of medicine, as chosen by experts in their respective fields. One of the most remarkable stories in medicine must be the r...

see more →

Patient Education  3 results see all →